Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
1627607-87-7
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:function |
LRRK2 inhibitor
|
| gptkbp:hasMolecularFormula |
C24H22F3N5O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
PF-06447475
|
| gptkbp:intendedUse |
treatment of Parkinson's disease
|
| gptkbp:mechanismOfAction |
kinase inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
gptkb:LRRK2
|
| gptkbp:bfsParent |
gptkb:LRRK2
|
| gptkbp:bfsLayer |
7
|